Zygomatic Bone Reabsorption
What is Zygomatic Bone Reabsorption?
The zygomatic bone, often called the cheekbone or malar bone, forms the prominence of the cheek, the lateral wall of the orbit, and part of the infraorbital rim. Zygomatic bone reabsorption refers to the progressive loss of bone tissue from this structure. The process is similar to the way calcium is withdrawn from other bones in conditions such as osteoporosis, but it is localized to the cheek area. Over time, the bone becomes thinner, weaker, and may change the contour of the face.
Reabsorption can be silent for months or years, only becoming apparent when facial asymmetry, functional problems (e.g., vision changes) or pain develop. Because the zygoma supports the orbit, severe loss may affect eye protection and the attachment of facial muscles.
Common Causes
Most cases are secondary to an underlying disease or external factor. The following are the most frequently reported contributors:
- Chronic sinusitis or maxillary sinus disease – long‑standing inflammation can stimulate bone remodeling.
- Osteoporosis – systemic loss of bone density may involve the facial skeleton.
- Rheumatoid arthritis or other systemic inflammatory arthritides – cytokines promote bone resorption.
- Paget’s disease of bone – abnormal bone turnover can cause localized expansion and subsequent resorption.
- Neoplastic processes – primary bone tumors (e.g., osteosarcoma) or metastases from breast, lung, or prostate cancer.
- Chronic use of corticosteroids – systemic steroids accelerate bone loss.
- Infectious osteomyelitis – bacterial infection of the zygoma leads to bone destruction.
- Post‑traumatic remodeling – after facial fractures, the bone may undergo excessive resorption during healing.
- Implant‑related complications – dental or cosmetic implants that exert pressure on the zygoma can cause pressure‑induced atrophy.
- Genetic disorders – conditions such as fibrous dysplasia or osteogenesis imperfecta may involve the cheekbones.
Associated Symptoms
Because the zygomatic bone is part of the facial scaffold, reabsorption often presents with a combination of aesthetic and functional signs:
- Gradual flattening or depression of the cheek
- Facial asymmetry that becomes noticeable when smiling or talking
- Hollowing under the eye (malar fat pad descent)
- Palpable tenderness or a “step” feeling along the orbital rim
- Vision disturbances if the orbital floor thins (e.g., double vision)
- Dryness or crusting in the lower eyelid due to loss of support
- Dental malocclusion if the maxillary arch shifts
- Occasional numbness or tingling in the cheek or upper lip (infra‑orbital nerve involvement)
- Facial swelling or redness when an infection is present
When to See a Doctor
Prompt evaluation is important to distinguish benign remodeling from serious pathology. Seek professional care if you notice any of the following:
- Rapid change in cheek contour over weeks to months
- Persistent pain that is not relieved with over‑the‑counter analgesics
- Swelling, warmth, or fever suggesting infection
- New onset double vision, drooping eyelid, or eye movement restriction
- Numbness, tingling, or loss of sensation in the face
- History of cancer, recent trauma, or chronic steroid use
- Difficulty chewing or changes in bite alignment
Diagnosis
Diagnosing zygomatic bone reabsorption involves a combination of clinical assessment and imaging studies.
Clinical Examination
- Visual inspection for asymmetry, hollowness, or skin changes.
- Palpation to assess bone thickness and tenderness.
- Neurological testing of the infra‑orbital nerve.
- Ophthalmologic evaluation if orbital involvement is suspected.
Imaging
- CT scan (computed tomography) – the gold standard for bony detail; shows exact area and depth of resorption.
- Cone‑beam CT (CBCT) – lower radiation dose, useful in dental settings.
- Panoramic radiograph – may reveal gross changes but is less sensitive.
- MRI – helps evaluate soft‑tissue masses or inflammatory disease adjacent to bone.
- DEXA scan – if systemic osteoporosis is suspected.
Laboratory Tests
- Complete blood count (CBC) and inflammatory markers (ESR, CRP) if infection or systemic inflammation is a concern.
- Serum calcium, vitamin D, and parathyroid hormone levels for metabolic bone disease.
- Tumor markers or biopsy when a neoplastic process is in the differential.
Treatment Options
Therapy is tailored to the underlying cause, the extent of bone loss, and the patient’s cosmetic and functional goals.
Medical Management
- Address underlying disease – e.g., bisphosphonates or denosumab for osteoporosis; disease‑modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis.
- Antibiotic therapy – for osteomyelitis or sinus infection (culture‑directed when possible).
- Corticosteroid-sparing regimens – taper systemic steroids when feasible.
- Hormone replacement or vitamin D/calcium supplementation – to improve bone metabolism.
- Pain control – NSAIDs, acetaminophen, or short courses of opioids under supervision.
Surgical & Procedural Interventions
- Bone grafting – autograft (iliac crest) or allograft material placed to rebuild the zygoma.
- Custom facial implants – porous polyethylene or titanium meshes fashioned from CT data.
- Orbital floor reconstruction – when the orbital rim is compromised to protect the eye.
- Sinus surgery (FESS) – functional endoscopic sinus surgery to treat chronic sinus disease that drives bone loss.
- Laser or radiofrequency ablation – in selected tumor cases to reduce size before reconstruction.
Home & Lifestyle Measures
- Maintain a calcium‑rich diet (dairy, leafy greens, fortified foods).
- Get 800–1000 IU of vitamin D daily, or as advised by a physician.
- Engage in weight‑bearing exercise (e.g., brisk walking, resistance training) 3–4 times per week.
- Avoid smoking and limit alcohol, both of which accelerate bone loss.
- Use protective eyewear during activities that could cause facial trauma.
- Follow postoperative care instructions carefully—avoid pressure on the cheek, keep the surgical site clean, and attend all follow‑up appointments.
Prevention Tips
While not all causes are preventable, several strategies reduce the risk of significant zygomatic reabsorption:
- Screen for and treat osteoporosis early, especially in post‑menopausal women and older men.
- Manage chronic sinus disease with nasal saline irrigations, nasal steroids, and prompt treatment of infections.
- Limit long‑term systemic corticosteroid use; discuss alternative therapies with your physician.
- Maintain good oral hygiene and regular dental check‑ups to detect early implant‑related issues.
- Participate in routine physical activity and a balanced diet rich in bone‑supporting nutrients.
- Wear protective gear (helmets, face shields) during sports or work that pose a risk of facial injury.
- Schedule regular ophthalmologic exams if you have known orbital or sinus disease.
Emergency Warning Signs
These findings require immediate medical attention (call 911 or go to the nearest emergency department):
- Sudden severe facial pain with swelling and fever – possible abscess or aggressive infection.
- Rapidly worsening vision, double vision, or new blindness.
- Uncontrolled bleeding from the nose or mouth after facial trauma.
- Signs of sepsis: high fever, rapid heart rate, confusion, or low blood pressure.
- Significant facial deformity that develops within hours to a few days.
Sources: Mayo Clinic, Cleveland Clinic, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Centers for Disease Control & Prevention (CDC), World Health Organization (WHO), peer‑reviewed articles from Journal of Oral and Maxillofacial Surgery and Bone journal (2022‑2024).
```